15 June 2021

Inflammatory disorders, including autoimmune disease, chronic infections and cancer are characterized by over-activation of the immune system. One of the key pathways involved in inflammation is interleukin-6 receptor (IL-6R) signalling which is a therapeutic target in sepsis, rheumatoid arthritis, haematological cancers and COVID-19. Still many patients do not respond to anti-IL-6(R) treatment, and one of the problems is our limited understanding of the IL-6R multimeric protein complex. We previously discovered that the IL-6R complex is inhibited by tetraspanin CD37 in the membrane of tumor cells.

Annemiek van Spriel (Dept. of Tumor Immunology, theme cancer development and immune defense) together with Piet Gros (Dept. of Chemistry, Utrecht University) obtained a ZonMw Open Competition Grant (750K Euro) to investigate IL-6 receptor structure and signalling in tumor cells in order to develop proof-of-concept therapy of targeting tetraspanin-cytokine receptor complexes in cancer.‚Äč This ZonMw project aims to deliver 1) conceptual new molecular insight into cytokine receptor complexes in cancer cells, and 2) new prospective to target tetraspanin building blocks to inhibit cancer growth and inflammation.   

more information 

Related news items


Laurens Verscheijden awarded doctorate degree 'cum laude'

19 January 2022

Laurens Verscheijden of the Department of Pharmacology and Toxicology, defended his PhD thesis, entitled "Mechanistic models for the prediction of brain drug exposure and response in the paediatric population: A virtual child reaching maturation.

read more

Aerobe exercise has a positive effect on brain function in Parkinson's disease patients

18 January 2022

Radboudumc researchers have shown that the brain function of patients with Parkinson's disease improved with regular exercise, which seems to strengthen the connections between different brain areas, while inhibiting brain shrinkage.

read more

Last call for nominations for the RIHS Awards 2021 Deadline for submission is 25 January 2022

18 January 2022

RIHS researchers are invited to propose candidates for the RIHS PhD Award, the Societal Impact Award, the Science Award, the Supervisor of the Year Award, and the RIHS Patient Involvement Award.

read more

Rogier Kievit and Geert Litjens both receive ERC Starting Grant of 1.5 million euros Board of Directors congratulates researchers on top grant

13 January 2022

Researchers Rogier Kievit and Geert Litjens were today festively welcomed by the Board of Directors, because of the ERC Starting Grants they both received. With these European top grants, they can each design an ambitious research project and put together their own research group.

read more

Improved AI will boost cancer research and cancer care Geert Litjens receives ERC Starting Grant

13 January 2022

Geert Litjens from Radboud university medical center has received a European Research Council (ERC) Starting Grant.

read more